Showing results (301-310 of 666) with videos related to
Sort By:
Pageof 67
Current Problems in Cancer|May 2, 2026
BCMA-directed CAR-T cell therapy in relapsed/refractory multiple myeloma: efficacy, safety, survival, and future directions - A systematic review and meta-analysisMuhammad Shaheer Mannan, Adeena Musheer, Muhammad Waqas Khan, et al.Current Problems in Cancer|May 9, 2026
Artificial intelligence, omics, and biomarkers: Redefining lung cancer early detectionAnam Nizam, Nawal Shireen, Mohd Rahil Hasan, et al.Current Problems in Cancer|June 9, 2026
Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer databaseMuni Rubens, Jeremy Purow, Daniel M Portnoy, et al.Current Problems in Cancer|July 10, 2026
Predictors of pathological upgrading in low-risk gleason grade group 1 prostate cancer on prostate biopsy: the role of clinical and tumor-specific factorsShirin Razdan, Ali Fathollahi, Alexandre Armache, et al.Current Problems in Cancer|July 24, 2026
Multicenter retrospective study on the clinical profiles of patients with extensive-stage small-cell lung cancer who met the eligibility criteria for clinical trialsTatsuya Yazaki, Kei Sonehara, Toshiharu Tsutsui, et al.Current Problems in Cancer|August 1, 2026
Blinatumomab versus chemotherapy in pediatric B-ALL: A meta-analysis of randomized trials in relapsed and high-risk frontline diseaseAdeena Musheer, Muhammad Shaheer Mannan, Muhammad Waqas Khan, et al.Current Problems in Cancer|August 28, 2026
Intraductal papillary mucinous neoplasms: a comprehensive analysis combining genetic, immunopathological and clinical managementGiovanni Izzo, Pietro Tralongo, Marina Cerreto, et al.Current Problems in Cancer|June 1, 1979
The detection and diagnosis of early occult and minimal breast cancerH S Gallager, J E Martin, D L Moore, et al.Current Problems in Cancer|March 24, 2020
VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literatureTugba Akin Telli, Ilker Nihat Okten, Tuğba Basoglu Tuylu, et al.Current Problems in Cancer|June 16, 2021
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?Giuseppe Fallara, Marco Bandini, Alessandro Larcher, et al.Pageof 67